Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001641172-25-001750
Filing Date
2025-03-31
Accepted
2025-03-31 16:20:44
Documents
97
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 2080048
2 ex21-1.htm EX-21.1 3888
3 ex23-1.htm EX-23.1 2194
4 ex31-1.htm EX-31.1 9036
5 ex31-2.htm EX-31.2 9155
6 ex32-1.htm EX-32.1 4014
7 ex32-2.htm EX-32.2 4207
  Complete submission text file 0001641172-25-001750.txt   8245327

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE vvos-20241231.xsd EX-101.SCH 55821
9 XBRL CALCULATION FILE vvos-20241231_cal.xml EX-101.CAL 80261
10 XBRL DEFINITION FILE vvos-20241231_def.xml EX-101.DEF 210712
11 XBRL LABEL FILE vvos-20241231_lab.xml EX-101.LAB 488952
12 XBRL PRESENTATION FILE vvos-20241231_pre.xml EX-101.PRE 389354
99 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1091235
Mailing Address 7921 SOUTHPARK PLAZA, SUITE 210 LITTLETON CO 80120
Business Address 7921 SOUTHPARK PLAZA, SUITE 210 LITTLETON CO 80120 (866)908-4867
Vivos Therapeutics, Inc. (Filer) CIK: 0001716166 (see all company filings)

EIN.: 813224056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39796 | Film No.: 25793576
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)